Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001213
Accepted
2025-04-24 00:15:09
Documents
1
Effectiveness Date
2025-04-23

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-25-001213.txt   2072
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286557 | Film No.: 25863379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)